Communiqué de presse
ViiV Healthcare announces European Commission Decision for Vocabria (cabotegravir) and Rekambys (rilpivirine) injections to be initiated with or without an oral lead-in period for the long-acting treatment of HIV
PRESS RELEASE For media and investors only Healthcare professionals and people living with HIV now have the choice of starting […]